Drug use in the United Kingdom is among the highest reported in Western Europe and people who inject drugs (PWID) experience stark health inequalities, with increased morbidity and early mortality. This report explores infections, as well as associated risks and behaviours, among people who inject drugs in the UK to the end of 2019. It also presents preliminary data on the impact of COVID-19 on PWID and services in 2020.
Related resources
-
Shooting Up: infections among people who inject drugs in the UK, 2019
UK, England, Northern Ireland, Scotland, Wales 28 Jan 2021 Reports & Research PDF -
Northern Ireland Hepatitis C Elimination Plan
This Northern Ireland Department of Health and Public Health Agency action plan sets out the approach to eliminating hepatitis C in Northern Ireland by 2025, five years ahead of the World Health Organization 2030 target.Northern Ireland 20 Jan 2021 Reports & Research, Strategy & Planning PDF -
Cost-effectiveness of opt-out HCV and HBV testing in A&E in the UK
Research published in Value in Health in December 2020 found that testing for hepatitis C and hepatitis B in A&E departments in the UK is highly likely to be cost effective due to high rates of hepatitis among people who attend A&E. Based on a study of two London hospitals, the paper argues that, just as NICE guidelines recommend testing people attending A&E for HIV, hepatitis C and hepatitis B testing should also occur.UK 22 Dec 2020 Reports & Research PDF -
Hepatitis C testing and treatment interventions for the homeless population in London during the Covid-19 pandemic: Outcomes and learning
This report from the London Joint Working Group on Substance Use and Hepatitis C outlines the outcomes and learnings of hepatitis C testing and treatment interventions for the homeless population during the Covid-19 pandemic. The report reveals that over 1,000 people were tested for blood-borne viruses over the course of 98 testing events in London between May and August 2020. Of those tested, 11% were positive for hepatitis C antibodies and 7% had an active infection.England, Greater London 17 Dec 2020 Reports & Research PDF -
The impact of the COVID-19 pandemic on prevention, testing, diagnosis and care for sexually transmitted infections, HIV and viral hepatitis in England
This Public Health England report covers the findings of analyses of the impact of the COVID-19 pandemic response on sexually transmitted infection (STI), HIV and viral hepatitis service provision and epidemiology. Despite a resurgence in hepatitis C testing and treatment initiations from June 2020, testing and treatment initiations in the summer of 2020 were considerably lower than in corresponding months in 2019. The report notes that "HCV testing through traditional venues may not have reached those in greatest need", describing this is "of particular concern".England 17 Dec 2020 Reports & Research PDF